InflaRx Days Sales Outstanding from 2010 to 2024

IFRX Stock  USD 2.36  0.05  2.16%   
InflaRx NV Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding is likely to outpace its year average in 2024. During the period from 2010 to 2024, InflaRx NV Days Sales Outstanding regression line of annual values had r-squared of  0.73 and arithmetic mean of  10,111. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
19.7 K
Current Value
20.7 K
Quarterly Volatility
11 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check InflaRx NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InflaRx NV's main balance sheet or income statement drivers, such as Interest Income of 3.2 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 342.2 K, as well as many indicators such as Price To Sales Ratio of 788, Dividend Yield of 0.0 or PTB Ratio of 0.83. InflaRx financial statements analysis is a perfect complement when working with InflaRx NV Valuation or Volatility modules.
  
Check out the analysis of InflaRx NV Correlation against competitors.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

Latest InflaRx NV's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of InflaRx NV over the last few years. It is InflaRx NV's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InflaRx NV's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

InflaRx Days Sales Outstanding Regression Statistics

Arithmetic Mean10,111
Geometric Mean1,722
Coefficient Of Variation108.73
Mean Deviation10,583
Median189.61
Standard Deviation10,994
Sample Variance120.9M
Range21.7K
R-Value0.85
Mean Square Error35.4M
R-Squared0.73
Significance0.000053
Slope2,097
Total Sum of Squares1.7B

InflaRx Days Sales Outstanding History

202420.7 K
202319.7 K
201821.9 K

About InflaRx NV Financial Statements

InflaRx NV investors use historical fundamental indicators, such as InflaRx NV's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in InflaRx NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding19.7 K20.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.